Naviter Wealth’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
DAM
F
Naviter Wealth's NVO Position: Q1 2026 in Review
Naviter Wealth increased its Novo Nordisk (NVO) stake by 5.9% in Q1 2026, buying an estimated $89.1K and bringing the position to 34,012 shares worth $1.29M. The position accounts for 0.16% of the portfolio, ranked #135.
Naviter Wealth first reported a position in NVO in Q2 2022 and has held it in 16 quarters since. The position peaked at $8.84M in Q2 2024. 1,273 funds tracked by Wall St. Rank hold NVO as of Q1 2026.
- Naviter Wealth held 34,012 shares of Novo Nordisk worth $1.29M as of Q1 2026.
- Naviter Wealth bought 1,881 Novo Nordisk shares in Q1 2026, an estimated $89.1K.
- Novo Nordisk made up 0.16% of Naviter Wealth's portfolio in Q1 2026, its #135 holding.
- Naviter Wealth first reported a position in Novo Nordisk in Q2 2022 and has held it in 16 quarters since.
- Naviter Wealth's Novo Nordisk position peaked at $8.84M in Q2 2024.
- 1,273 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.
Based on Naviter Wealth's 13F filing for Q1 2026, filed 10 Apr 2026.